Jefferies Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-8,300
Closed -$1.59M 2919
2019
Q4
$1.59M Sell
8,300
-83,100
-91% -$15M 0.01% 1177
2019
Q3
$15.4M Sell
91,400
-204,100
-69% -$33.3M 0.12% 117
2019
Q2
$49.5M Buy
295,500
+292,800
+10,844% +$40.5M 0.36% 28
2019
Q1
$395K Sell
2,700
-93,700
-97% -$13.6M ﹤0.01% 1694
2018
Q4
$12.9M Buy
96,400
+28,300
+42% +$4.64M 0.11% 149
2018
Q3
$13M Sell
68,100
-71,400
-51% -$13.1M 0.08% 201
2018
Q2
$23.3M Buy
139,500
+15,100
+12% +$2.42M 0.13% 99
2018
Q1
$20.9M Sell
124,400
-150,600
-55% -$25.3M 0.11% 110
2017
Q4
$45M Buy
275,000
+97,500
+55% +$17.5M 0.21% 55
2017
Q3
$36.4M Buy
177,500
+5,600
+3% +$1.3M 0.24% 58
2017
Q2
$41.8M Sell
171,900
-151,600
-47% -$35.6M 0.28% 50
2017
Q1
$77.3M Sell
323,500
-1,019,900
-76% -$238M 0.58% 15
2016
Q4
$282M Sell
1,343,400
-167,000
-11% -$34.6M 1.58% 5
2016
Q3
$348M Sell
1,510,400
-288,500
-16% -$70.5M 1.79% 6
2016
Q2
$416M Buy
1,798,900
+580,200
+48% +$134M 1.89% 8
2016
Q1
$327M Buy
1,218,700
+46,700
+4% +$13.4M 1.88% 6
2015
Q4
$366M Buy
1,172,000
+978,600
+506% +$291M 2.08% 6
2015
Q3
$52.6M Buy
193,400
+148,800
+334% +$45.7M 0.3% 51
2015
Q2
$13.5M Sell
44,600
-275,900
-86% -$82.3M 0.07% 228
2015
Q1
$95.4M Buy
320,500
+5,100
+2% +$1.45M 0.53% 26
2014
Q4
$81.2M Sell
315,400
-9,800
-3% -$2.45M 0.48% 36
2014
Q3
$78.5M Buy
325,200
+92,400
+40% +$20.7M 0.54% 29
2014
Q2
$51.9M Buy
+232,800
New +$48.2M 0.44% 43
2013
Q3
Sell
-130,000
Closed -$16.4M 2294
2013
Q2
$16.4M Buy
+130,000
New +$14.7M 0.18% 88

Other funds holding AGN

Jefferies Group's AGN Position: Q2 2020 in Review

Jefferies Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 269,542 shares — an estimated $47.7M sold.

Jefferies Group first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $81.1M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jefferies Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 269,542 Allergan plc shares in Q2 2020, an estimated $47.7M.
  • Jefferies Group first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Jefferies Group's Allergan plc position peaked at $81.1M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.